How to buy TC BioPharm Holdings stock (TC BioPharm)

TC BioPharm Holdings is a biotechnology business based in the US. TC BioPharm Holdings shares (TCBP) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.71 – an increase of 7.58% over the previous week. TC BioPharm Holdings employs 41 staff and has a trailing 12-month revenue of around $2.9 million.

Our top picks for where to buy TC BioPharm stock

Buy TC BioPharm Holdings stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

TC BioPharm Holdings stock price (NASDAQ: TCBP)

Use our graph to track the performance of TCBP stocks over time.

TC BioPharm Holdings shares at a glance

• Key figures

Information last updated 2024-12-22.

Latest market close	$0.71
52-week range	$0.44 - $41.50
50-day moving average more info button	$3.86
200-day moving average more info button	$8.94
Wall St. target price	$140.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-192.95

Is it a good time to buy TC BioPharm Holdings stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

TC BioPharm Holdings price performance over time

Historical closes compared with the close of $0.71 from 2024-12-27

1 week (2024-12-20)	7.58%
1 month (2024-11-29)	26.81%
3 months (2024-09-27)	-86.80%
6 months (2024-06-28)	-13.87%

1 year (2023-12-29)	-77.60%
2 years (2022-12-29)	-99.89%
3 years (2021-12-25)	N/A
5 years (2019-12-25)	N/A

TC BioPharm Holdings financials

Revenue TTM	$2.9 million
Gross profit TTM	$3.8 million
Return on assets TTM	-108.92%
Return on equity TTM	-1217.48%
Profit margin	0%
Book value	$3.38
Market Capitalization more info button	$360,373

TTM: trailing 12 months

TC BioPharm Holdings share dividends

We're not expecting TC BioPharm Holdings to pay a dividend over the next 12 months.

You may also wish to consider:

• Gilead Sciences (GILD.US) (3.33% forward annual dividend yield)

Have TC BioPharm Holdings's shares ever split?

TC BioPharm Holdings's shares were split on a 1:10 basis on 4 August 2024 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your TC BioPharm Holdings shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for TC BioPharm Holdings shares which in turn could have impacted TC BioPharm Holdings's share price.

TC BioPharm Holdings share price volatility

Over the last 12 months, TC BioPharm Holdings's shares have ranged in value from as little as $0.4359 up to $41.5. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while TC BioPharm Holdings's is 0.249. This would suggest that TC BioPharm Holdings's shares are less volatile than average (for this exchange).

To put TC BioPharm Holdings's beta into context you can compare it against those of similar companies.

• Caladrius Biosciences (CLBS.US): 0.9133
• Harpoon Therapeutics (HARP.US): 2.098
• Gilead Sciences (GILD.US): 0.192

TC BioPharm Holdings overview

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom. .

Frequently asked questions

What percentage of TC BioPharm Holdings is owned by insiders or institutions?
Currently 0.006% of TC BioPharm Holdings shares are held by insiders and 1.763% by institutions. How many people work for TC BioPharm Holdings?
Latest data suggests 41 work at TC BioPharm Holdings. When does the fiscal year end for TC BioPharm Holdings?
TC BioPharm Holdings's fiscal year ends in December. Where is TC BioPharm Holdings based?
TC BioPharm Holdings's address is: Maxim 1, Motherwell, United Kingdom, ML1 4WR What is TC BioPharm Holdings's ISIN number?
TC BioPharm Holdings's international securities identification number is: US87807D1037